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Abstract
Background: Chikungunya virus (CHIKV) is a mosquito-borne, arthrogenic Alphavirus that causes large epidemics in
Africa, South-East Asia and India. Recently, CHIKV has been transmitted to humans in Southern Europe by invading
and now established Asian tiger mosquitoes. To study the processing of envelope proteins E1 and E2 and to
develop a CHIKV subunit vaccine, C-terminally his-tagged E1 and E2 envelope glycoproteins were produced at
high levels in insect cells with baculovirus vectors using their native signal peptides located in CHIKV 6K and E3,
respectively.
Results: Expression in the presence of either tunicamycin or furin inhibitor showed that a substantial portion of
recombinant intracellular E1 and precursor E3E2 was glycosylated, but that a smaller fraction of E3E2 was
processed by furin into mature E3 and E2. Deletion of the C-terminal transmembrane domains of E1 and E2
enabled secretion of furin-cleaved, fully processed E1 and E2 subunits, which could then be efficiently purified
from cell culture fluid via metal affinity chromatography. Confocal laser scanning microscopy on living baculovirus-
infected Sf21 cells revealed that full-length E1 and E2 translocated to the plasma membrane, suggesting similar
posttranslational processing of E1 and E2, as in a natural CHIKV infection. Baculovirus-directed expression of E1
displayed fusogenic activity as concluded from syncytia formation. CHIKV-E2 was able to induce neutralizing
antibodies in rabbits.
Conclusions: Chikungunya virus glycoproteins could be functionally expressed at high levels in insect cells and are
properly glycosylated and cleaved by furin. The ability of purified, secreted CHIKV-E2 to induce neutralizing
antibodies in rabbits underscores the potential use of E2 in a subunit vaccine to prevent CHIKV infections.
Background
Chikungunya virus (CHIKV) is an arthropod-borne
(arbo)virus that causes epidemics in Africa, India and
South-East Asia [1]. Recent outbreaks in Italy in 2007
[2] and autochthonous transmission events in France in
2010 [3] exemplify the threat of continued spread of
CHIKV in the Western world, which correlates with the
concurrent expanding distribution of its insect vector.
CHIKV is maintained in a sylvatic transmission cycle of
mosquitoes, rodents and primates, with Aedes aegyti as
the primary vector. However, the responsible vector
causing the severe CHIKV epidemic on the Reunion
Islands in 2005/2006 was Ae. albopictus [4]. This vector
switch made the virus endemic in more temperate
regions and resulted in the first European cases (Italy,
2007) of transmission by local populations of Ae. albo-
pictus [1,5].
CHIKV (family Togaviridae:g e n u sAlphavirus)h a sa
single-stranded positive-sense RNA genome, which var-
ies slightly in length between different isolates, but is
approximately 11,800 nts long [6] and encodes two
open reading frames (ORF). The RNA is encapsidated in
a nucleocapsid of approximately 40 nm in diameter [7].
The nucleocapsid is tightly enveloped by a host-derived
lipid bilayer (envelope) supporting the virus-encoded
envelope proteins. Eighty glycoprotein spikes are C-
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exposed on the surface of virions and of infected cells.
The nonstructural proteins required for viral RNA
replication are directly translated from the 5’ two-thirds
region of the viral genome. The structural polyprotein is
translated from a viral subgenomic mRNA (sgRNA),
located at the 3’one-third part of the genome [8,9]. The
five structural proteins (capsid, E3, E2, 6K, E1) are
translated as a single polyprotein, from which capsid (C)
is autocatalytically cleaved off to encapsidate new plus-
strand RNA molecules. The envelope polyprotein pre-
cursor E3-E2-6K-E1 is then translocated to the endo-
plasmatic reticulum (ER). Host signalases process the
polyprotein at the N- and C-terminal end of the 6K
peptide, resulting in E3E2 (also known as precursor E2:
PE2), 6K and E1 [10], all anchored in the ER membrane.
After this proteolytic cleavage, E3E2 and E1 will even-
tually form heterotrimers in the early Golgi compart-
ment. Subsequently, E3E2 undergoes a furin-dependent
maturation cleavage in the trans-Golgi system at the
consensus cleavage signal R-X-(K/R)-R. This furin clea-
vage is not a prerequisite for virion assembly [11]. The
hetero-trimeric spikes consisting of E2 and E1 facilitate
cell receptor recognition, cell entry via pH-dependent
endocytosis and support viral budding [9].
The major clinical symptoms of a CHIKV infection
are febrile illness and severe joint pains [12]. Recently,
macrophages were identified as being key players in
CHIKV infection, persistence and pathogenesis. Macro-
phage-derived pro-inflammatory products are strongly
involved in the muscle and joint immunopathological
findings after alphavirus infection [13,14]. Currently,
there are no specific treatments for CHIKV infections
and no licensed vaccine for any alphavirus is available
for human use. During an infection with the alphavirus
type species Sindbis virus (SINV) neutralizing antibodies
are generally directed against E2 and to a lesser extent
to E1. This holds true for other alphaviruses as well,
suggesting that E1 and E2 are conserved among alpha-
viruses as epitope donors [15,16]. Therefore glycopro-
teins E1 and E2 serve as the major targets in the
development of a (subunit) vaccine against CHIKV
infections. A recently developed, experimental CHIKV
vaccine based on virus-like particles (VLPs) containing
both E1 and E2 induced a protective immune response
in non-human primates [17]. While this VLP approach
may be a way forward in the development of a CHIKV
vaccine, the described method of transfecting large
DNA plasmids into mammalian cells remains challen-
ging in terms of upscaling. Therefore, a subunit
approach may be better compatible with industrial
operations [18,19].
In this study, the baculovirus-insect cell expression
system was used to study recombinant CHIKV
glycoprotein subunit formation. This production system
is a safe and efficient way of expressing heterologous
proteins on a large scale in eukaryotic cells [20] and the
proven technology has resulted in several commercially
available veterinary vaccines [21], including a veterinary
subunit vaccine targeting Classical Swine Fever [18] and
a human vaccine against cervical cancer (Cervarix, Glax-
oSmithKline) [22]. A recombinant human vaccine
against influenza virus (FluBlok) Biological License
Application is currently in the process of evaluation by
the Food and Drug Administration in the USA [19].
Recombinant protein expression by baculoviruses is
based on the use of the strong polyhedrin promoter and
the exchange of the polyhedrin gene for the heterolo-
gous gene of interest. This late phase baculoviral protein
is expressed in large amounts in infected cells, but is
not essential for baculovirus replication [23]. Further-
more, protein expression in insect cells allows post-
translational modifications, accurate folding and efficient
secretion [21,24]. Drosophila cells have recently been
used to efficiently express and process CHIKV-glycopro-
tein complexes [25], yet there are few reports on suc-
cessful expression of alphavirus structural polyproteins
with recombinant baculoviruses [26,27], and there are
no studies that describe the expression of individual
full-length alphavirus E1 and/or E2 glycoproteins. Here,
we investigated the expression of individual CHIKV E1
and E2 glycoproteins in insect cells and analyzed the
routing and post-translation modifications of these gly-
coproteins as well as the fusogenic properties of recom-
binant E1. In addition, purification methods were
developed for secreted forms of these glycoproteins, of
which the ability to generate a neutralizing antibody
response was investigated.
Results
Expression of CHIKV-E2 and -E1 glycoproteins in Sf21
insect cells by recombinant baculoviruses
Four recombinant baculoviruses were generated to
express membrane attached and secreted versions of
CHIKV glycoproteins E1 and E2 (Ac-6KE1, Ac-
6KE1ΔTM, Ac-E3E2 and Ac-E3E2ΔTM) (Figure 1A).
The glycoprotein coding sequences were cloned down-
stream of the polyhedrin promoter in an Autographa
californica multicapsid nucleopolyhedrovirus (AcMNPV)
bacmid from which the promoters and open reading
frames of the p10, cathepsin and chitinase genes were
deleted (See Materials and Methods). All four glycopro-
tein constructs were equipped with a C-terminal 6 × his
tag. Sf21 insect cells were infected with the respective
recombinant baculoviruses at a MOI of 10 TCID50 units
per cell and cells were harvested 72 h post infection
(hpi), which appeared to be the optimal time point for
harvesting (data not shown). Recombinant protein
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brilliant blue (CBB)-staining and western analysis using
a-His monoclonal antibodies (mabs) and a-E1 and a-E2
polyclonal antisera (Figure 1B).
CBB staining of Sf21 cell lysates showed that CHIKV-
E2 and -E1 were expressed at very high levels. The size
of the proteins observed after infection with Ac-6KE1
and Ac-6KE1ΔTM (Figure 1B, lanes 1 and 2) closely
matched the predicted molecular mass of 6KE1 and
6KE1ΔTM of 54.2 kDa and 52.1 kDa, respectively.
CHIKV 6KE1 was not detected by western analysis
using a-His mabs, but was recognized well by a-E1
polyclonal antiserum. This is most likely caused by the
proteolysis of the C-terminal his-tag of CHIKV 6KE1.
Expression analysis of insect cells infected with Ac-E3E2
and Ac-E3E2ΔTM (Figure 1B, lane 3 and 4) resulted in
two polypeptides for each construct. The smallest ones
correspond to the predicted molecular mass of unpro-
cessed E3E2 (54.6 kDa) and E3E2ΔTM (49.2 kDa),
respectively. The larger ones, estimated to be 3-4 kDa
larger in size, are possibly glycosylated forms of E3E2
and E3E2ΔTM, respectively. When the cell fractions
were analyzed with the a-E2 polyclonal antiserum, a
third, smaller protein was seen, which most likely repre-
sents furin-processed, glycosylated E2 and E2ΔTM,
respectively. To allow secretion of E1 and E2 into the
cell culture fluid, the C-terminal transmembrane
domains of E1 and E2 were deleted (constructs Ac-
6KE1ΔTM and Ac-E3E2ΔTM). Medium fraction analy-
sis shows that the removal of the C-terminal TM of E1
and E2 indeed resulted in secretion of E1 and E2 (Figure
1B, bottom, lanes 2 and 4).
Glycosylation status of baculovirus expressed CHIKV-E1
and -E2
To analyze whether the size difference observed between
the upper and lower bands of E3E2 or E3E2ΔTM in
CBB and western blots (Figure 1B) can be attributed to
glycosylation of E2 a tunicamycin assay was performed
to analyze the N-glycosylation status of both glycopro-
teins. It is common knowledge that alphavirus E1 and
E2 are N-linked glycosylated, but the number of glycosy-
lation sites can vary among species [28-31]. CHIKV-E1
is predicted to be glycosylated at N141 and CHIKV-E2
at N263 and N273 [32]. Sf21 cells were infected with
the 4 recombinant baculoviruses, respectively, (Figure
1A) and incubated in the presence or absence of tunica-
mycin, harvested at 72 hpi and separated from the med-
ium fraction. Whole cell lysates were analyzed by
western blotting (Figure 2A) and by Periodic Acid Schiff
staining (Figure 2B), which stains glycosyl groups on
proteins [33].
Expression of 6KE1 and 6KE1ΔTM in tunicamycin
treated Sf21 cells resulted in a band with lower molecu-
l a rm a s s( F i g u r e2 A ,l e f t ) .T h i ss u g g e s t st h a tE 1i sa t
least partially glycosylated. PAS-staining of 6KE1 and
6KE1ΔTM resulted in protein bands with a size similar
to the proteins detected by western blotting and con-
firmed that CHIKV-E1 was glycosylated. Western blot
detection using a-E2 polyclonal antiserum showed that
infection with Ac-E3E2 and Ac-E3E2ΔTM resulted in
the triple-band pattern previously observed (Figure 1B).
Figure 1 CHIKV E1 and E2 expression using recombinant
baculoviruses. A) Schematic representation of four CHIKV
glycoprotein constructs expressed from recombinant baculoviruses.
The shaded areas represent transmembrane domains or signal
peptides (ss), asterisks indicate predicted N-glycosylation sites, S and
F indicate signalase and furin cleavage sites, respectively. The
predicted molecular mass of the glycoproteins is indicated. All
constructs were equipped with a C-terminal 6 × His-tail. B) Gene
expression in the cell and in medium fractions of infected Sf21 cells
was analyzed by Coomassie brilliant blue-staining and western
blotting using a-His mabs and rabbit a-E1 and rabbit a-E2
polyclonal antisera.
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observed occasionally and may represent E2 aggregates.
Upon tunicamycin treatment of Ac-E3E2 and Ac-
E3E2ΔTM-infected cells, the E2-specific polypeptides
with the highest molecular mass (~58 and ~55 kDa,
respectively) disappeared, suggesting that these are the
N-glycosylated forms of E3E2 and E3E2ΔTM (Figure
2A). PAS-staining, which is absent in the tunicamyin
treated lanes, confirmed this result. Thus it can be con-
cluded that the bands of ~55 kDa and ~49 kDa in infec-
tions with Ac-E3E2 and Ac-E3E2ΔTM, respectively,
represent non-glycosylated E3E2 and E3E2ΔTM pro-
teins. The smaller polypeptides of ~50 kDa and ~44
kDa, correspond in size to glycosylated, furin-cleaved E2
and E2ΔTM, respectively. PAS-staining on the Ac-
E3E2ΔTM infected cell fraction also stains this addi-
tional protein of ~44 kDa (Figure 2B), suggesting that
glycosylated, furin-cleaved E2ΔTM is indeed produced,
albeit in relatively low abundance. Immunodetection of
the baculovirus GP64 envelope protein was used as a
positive control (Figure 2C). GP64 is essential for bacu-
lovirus budding and cell entry, and is known to be heav-
ily glycosylated [34,35] at 4 of the 5 predicted positions
[36]. As expected, a significant decrease (~6 kDa) in
molecular mass was observed as a result of tunicamycin
treatment. GP64 is best detected on highly concentrated
budded virus preparations and more difficult in insect
cells. PAS staining is not sensitive enough to detect gly-
cans on minor amounts of GP64, compared to overex-
pressed CHIKV glycoproteins, which explains the lack
of PAS staining in cells infected the Ac-GFP control
virus (Figure 2B, right).
These results show that a substantial fraction of
CHIKV E1 and E2 proteins expressed by recombinant
baculoviruses in Sf21 insect cells is N-glycosylated and
that only a minor fraction of the glycosylated E3E2
precursor is processed by furin into mature, N-glycosy-
lated E2.
Furin processing of recombinant CHIKV-E3E2 and
-E3E2ΔTM
During natural alphavirus glycoprotein maturation, E3 is
released from E3E2 via cleava g eb yaf u r i n - l i k ep r o t e a s e
[11]. However, the triple-band patterns found during infec-
tion with Ac-E3E2 and Ac-E3E2ΔTM (Figure 2A, right)
suggest that the bulk of intracellular E3E2 is incompletely
processed by furin into the individual E3 and E2 proteins.
To investigate the level of furin-processing and to confirm
the nature of the smallest polypeptide in the triple-band
pattern, Sf21 cells were infected with Ac-E3E2 and Ac-
E3E2ΔTM in the presence or absence of furin inhibitor.
Western blot analysis of Ac-E3E2 infected cells shows
that the smallest polypeptide (~44 kDa) detected by anti-
E2 antiserum disappeared in the presence of furin inhibi-
tor (Figure 3A, left) indicating that this represents the
mature E2, which according to the previous experiment
was also N-glycosylated (Figure 2). As expected, all E2-
specific polypeptides were retained in the cell fraction
(Figure 3B, left) unless the TM was deleted (Figure 3B,
right) in accordance with the experiments showing that
E2 is only secreted when the C-terminal TM-domain was
deleted (Figure 1B). It should be noted that furin-pro-
cessed E2ΔTM could hardly be observed in the cell frac-
tion, which might suggest that the protein is secreted
shortly after it is cleaved by furin in the trans-Golgi com-
plex. Interestingly, when furin cleavage was inhibited in
Ac-E3E2ΔTM-infected cells, the N-glycosylated fraction
of E3E2ΔTM was still secreted into the culture fluid (Fig-
ure 3B, right). It can therefore be concluded that secre-
tion of E2ΔTM is not dependent on furin processing.
Secretion of recombinant CHIKV-E1ΔTM and -E3E2ΔTM
from insect cells
The recombinant baculovirus expression analysis and
the furin inhibition assay showed that CHIKV E1ΔTM
Figure 2 N-linked glycosylation of CHIKV E1 and E2
synthesized with baculovirus vectors. A) Infected Sf21 cells were
treated with tunicamycin and cell fractions were analyzed by
western blotting using a-E1 and a-E2 polyclonal antisera. B)
Glycosylation of recombinant CHIKV E1 and E2 was confirmed by
PAS-staining. C) Detection of baculovirus glycoprotein GP64 verified
tunicamycin activity.
Figure 3 Furin inhibiton assay on Ac-E3E2 and Ac-E3E2ΔTM
infected Sf21 cells. Sf21 cells were infected with Ac-E3E2 and Ac-
E3E2ΔTM in the absence (-) or presence (+) of furin inhibitor. The
cell fraction (A) and the concentrated medium fraction (B) were
analyzed by western blotting using a-E2 polyclonal antiserum.
Glycosylated proteins are indicated with an asterisk.
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expressed with their native signal peptide 6K and E3,
respectively (Figures 1B and 3B). To investigate whether
other heterologous signal peptides might have a stronger
effect on protein secretion, 6K and E3 were both
exchanged for the honey bee melittin signal peptide
(HBM), which has been shown to improve both expres-
sion and secretion of heterologous proteins in baculo-
virus infected cells [37]. In other constructs, the first 41
amino acids from 6K were deleted as they are not part
of the signal peptide necessary for ER translocation of
E1. The remaining 6K signal sequence was cloned
upstream of E1ΔTM (Ac-6K
-40E1ΔTM) and of E2ΔTM
(Ac-6K
-40E2ΔTM). The level of intracellular or secreted
E1 and E2 was compared by western blotting. A control
lane of CHIKV-infected Ap61 mosquito cells was loaded
to indicate the size of native E1 and E2 proteins.
The replacement of 6K for HBM upstream of
E1ΔTM resulted in lower intracellular E1 levels (Figure
4A), while the secretion level was also dramatically
decreased (Figure 4B). Deletion of the first 41 amino
acids from 6K resulted in equal secretion levels com-
pared to the native complete signal peptide 6K. It
could be concluded that the signal sequence in 6K is
sufficient for efficient secretion of E1ΔTM. When the
same signal peptides were exchanged with E3 to test
whether E2ΔTM secretion could be enhanced, all con-
structs were expressed successfully (Figure 4A), but
medium fraction analysis showed that neither the
HBM nor the 6K
-40 signal sequence could improve
E2ΔTM protein secretion. This indicates that the
CHIKV-6K and E3 signal peptides direct E1ΔTM and
E2ΔTM secretion better than other well studied signal
peptides like the HBM signal sequence. These results
suggest that the CHIKV signal peptides could poten-
tially serve as strong signal peptides for secretion of
other heterologous proteins.
Purification of secreted recombinant CHIKV-E1ΔTM and
-E2ΔTM
Both Ac-6KE1ΔTM and Ac-E3E2ΔTM constructs were
tagged with a C-terminal polyhistidine-tail for detection
and purification purposes. Medium fraction analyses
showed that E1ΔTM and E2ΔTM were effectively
secreted from the cell, which enables protein purifica-
tion by Co
2+-histidine interaction. Total medium frac-
tions were loaded onto Talon
® spin columns and bound
proteins were eluted with 150 mM imidazol. CBB ana-
lyses of the three elution fractions (Figure 5A) showed a
dramatic increase in concentration of both E1ΔTM and
E2ΔTM compared to the non-purified fractions, indicat-
ing that both recombinant proteins were efficiently puri-
fied from the medium fraction. Western analyses using
the polyclonal antisera (Figure 5B) confirmed that the
purified fractions indeed contained E1ΔTM and E2ΔTM
and that multiple elution steps are required to comple-
tely elute the recombinant CHIKV glycoproteins from
the column. Two bands were detected in the elution
fractions of Ac-E3E2ΔTM (Figure 5B, right). The pro-
tein band with the highest molecular mass most likely
represents glycosylated E3E2ΔTM, which complies with
the finding that secretion of E2ΔTM is not dependent
on furin cleavage (Figure 3B). Protein concentrations in
the elution fractions were determined by Bradford assay
and resulted in a total yield of 38 and 30 mg/l secreted
protein for CHIKV-E1ΔTM and CHIKV (E3)E2ΔTM,
respectively, at a cell concentration of 6.7 × 10
5 Sf21
cells/ml. Metal affinity purification of secreted CHIKV-
E1ΔTM and -E2ΔTM resulted in a protein recovery of
~60% and >95%, respectively.
Surface expression of CHIKV-E1 and -E2 in Sf21 cells
Alphavirus glycoproteins are, during a natural infection,
expressed at the surface of the host cell to allow
Figure 4 CHIKV E1ΔTM and E2 protein secretion.B o t hC H I K V
E1ΔTM and E2ΔTM were expressed with E3, HBM or 6K
-40 as signal
sequence. The cell fraction A) and the medium fraction B) were
analyzed by western blot using a-E1 and a-E2 polyclonal
antibodies. CHIKV infected Ap61 mosquito cell-lysate was used as a
control.
Figure 5 Purification of secreted, recombinant CHIKV E1ΔTM
and E2ΔTM proteins. Sf21 cells were infected with Ac-6KE1ΔTM
and Ac-E3E2ΔTM and the respective serum-free medium fractions
were loaded onto Talon
® spin columns. Bound proteins were
eluted 3 times with 150 mM imidazol. The elution fractions were
analyzed with CBB (A) and western blotting, using a-E1 and a-E2
polyclonal antisera (B). NP represents non-purified fractions and El.1-
3 indicate the subsequent elution fractions. Total protein
concentration of the elution fractions (1 ml each) are noted above
in μg/ml.
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experiments it became clear that baculovirus expressed
CHIKV E1 and E2 are (at least partially) glycosylated
and secreted from Sf21 cells when their C-terminal TM
domain is deleted. It was also observed that E3E2 is (at
least partially) processed by furin, suggesting that the
posttranslational processing of CHIKV glycoproteins in
baculovirus-infected cells may resemble the processing
during a natural CHIKV infection [10]. If this is the
case, E1 and E2 are expected to be transported to the
cell membrane during baculovirus infection and be
exposed at the cell surface.
Therefore, non-permeable, living Sf21 cells infected
with Ac-6KE1 or Ac-E3E2 were subjected to immuno-
fluorescence using polyclonal E1 and E2 antisera [38].
Positive staining indicated that the glycoproteins are
exposed at the surface of the cell (Figure 6). From the
ring-like structure observed by confocal microscopy
(Figure 6, top and middle) it could be concluded that
both E1 and E2 are translocated to the plasma mem-
brane when expressed in insect cells. This ring-like
structure was not observed in mock infected cells (Fig-
ure 6, bottom).
Fusogenic activity of CHIKV-E1 expressed in Sf21 cells
This study has shown that production of CHIKV E1 and
E2 insect cells using baculovirus vectors leads to glyco-
sylation, (partial) furin processing and plasma membrane
translocation and/or secretion of E1 and E2. The indivi-
dually expressed glycoproteins appear to follow similar
processing steps as compared to wildtype CHIKV
infections [10], which might imply that the recombinant
glycoproteins retained their functionality. The following
experiment was designed to test the fusogenic activity of
baculovirus expressed E1, which in CHIKV infection
regulates fusion during endocytosis in a pH-dependent
manner, with a pH-optimum of 5.5 [39]. Since alphavrus
fusion is cholesterol dependent [40] and insect are cho-
lesterol auxotrophs, Sf9-ET cells were cultured in cho-
lesterol-supplemented Sf900 II insect medium (pH =
6.4) and were infected with Ac-6KE1, Ac-E3E2 and Ac-
GFP. Sf9-ET is a transgenic cell line expresing eGFP
under the control of the polyhedrin promoter, thereby
only allowing eGFP expression during baculovirus repli-
cation [41]. In this way, baculovirus infected cells could
be easily visualized. Therefore, Sf9-ET cells infected with
Ac-GFP express higher amounts of GFP, compared to
Ac-6KE1 and Ac-E3E2 infected Sf9-ET cells. Cells were
treated with acidified medium of pH = 5.8, pH = 5.5
and pH = 5.0. Cells were screened for syncytia forma-
tion 4 h post treatment. Syncytia formation after induc-
tion with medium of pH6.4, pH = 5.8 or pH = 5.5 was
only observed in cells producing CHIKV-E1 at 72 h.p.i
(Figure 7, right). In contrast, cells infected with Ac-E3E2
(Figure 7, middle) or Ac-GFP (Figure 7, left) did not
form syncytia, unless they were induced with acidified
medium of pH = 5.0 (Figure 7, bottom). At this low pH,
baculovirus GP64 induces syncytia formation [42]. Thus,
expression of E1 is correlated with syncytium formation
and E1 is functionally active as viral fusion protein in a
defined pH range. The fusogenicity of CHIKV E1 is in
the same order of magnitude to what has been found
for the major envelope fusion protein F of baculoviruses
with this particular assay suggesting that E1 is highly
fusogenic [43]. These data concerning pH-dependent
syncytia formation exclude the possibility that the syncy-
tia formation in this assay at pH values of 5.8 and 5.5
was caused by the baculovirus infection itself. These
findings are in line with the surface expression of
CHIKV-E1 (Figure 6) and indicate that E1 retains its
fusogenic activity when expressed in Sf-cells.
Virus neutralization test
Purified CHIKV-E1ΔTM and -E2ΔTM (Figure 5) were
used to generate polyclonal antisera in rabbits. To ana-
lyse the neutralizing activity of the polyclonal a-E1 and
a-E2, the antisera were incubated with 100 TCID50/ml
CHIKV and subsequently incubated for 4 days with
BHK-21 cells. Total suppression of cytopathic effect was
used as a microscopic marker for virus neutralization.
Rabbits vaccinated with CHIKV-E2ΔTM developed neu-
tralizing antibody titers against CHIKV, up to a dilution
of 1:40. No neutralizing antibodies were measured in
sera of the animals vaccinated with CHIKV-E1ΔTM.
The sera of CHIKV infected mice was used as a control
Figure 6 Surface expression of CHIKV E1 and E2 on the plasma
membrane. Sf21 cells were infected with recombinant
baculoviruses and living cells were immunostained against E1 and
E2. Confocal microscopy reveals the presence of CHIKV-E1 and-E2 at
the surface of infected Sf21 cells.
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results show that purified CHIKV-E2ΔTM, expressed by
recombinant baculoviruses, is able to induce neutralizing
antibodies in rabbits.
Discussion
The continued spread of CHIKV worldwide, the asso-
ciated threat for invasion of Europe and other Western
countries, and the economic impact of a CHIKV epidemic
highlights the demand for an effective antiviral therapy
and/or vaccine. Several attempts have been undertaken to
design such a vaccine and include the development of a
life attenuated CHIKV strain and, more recently, a VLP-
based approach [17]. VLPs have safety profiles very similar
to those of subunits and immunogenic properties compar-
able to killed vaccines. It has been shown that there is
great potential for the baculovirus expression system to
generate effective (subunit) vaccines [21] and several vac-
cines produced in this system are on the market or in the
process of registration. Furthermore, CHIKV is trans-
mitted by mosquitoes and replicates to high viral titers in
mosquitoes cells, thus it might be beneficial to express
CHIKV proteins in insect cells [44]. In this research, vac-
cine candidates were generated consisting of individual
CHIKV glycoproteins expressed in insect cells using
recombinant baculoviruses.
Figure 7 Syncytia formation after surface expression of CHIKV-E1 in insect cells. Sf9-ET cells in cholesterol supplemented Sf900 II medium
(pH = 6.4) were infected with Ac-6KE1, Ac-E3E2 and Ac-GFP. Cells were incubated 72 h post infection with medium of pH = 5.8, pH = 5.5 and
pH = 5.0 for 2 min. Pictures were taken 4 h post induction. Syncytia are indicated with arrows.
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of the polyhedrin promoter of baculovirus AcMNPV to
analyze individual expression of E1 and E2 with their
native signal peptides and in the presence or absence of
their respective C-terminal transmembrane domains.
Results of SDS-PAGE and western blot analyses indi-
cated that all proteins were expressed at high levels in
Sf21 cells and that a substantial fraction of these pro-
teins was processed in a similar fashion as during a nat-
ural CHIKV infection. The glycosylation patterns and
resulting size changes found for CHIKV E1 and E2
appear to correspond with the postulated number of
glycosylation sites in E1 and E2 (1 and 2, respectively).
Our findings are in agreement with results obtained in
glycoprotein expression studies for other alphaviruses
and for the related Rubellavirus,t h a tu s e dr e c o m b i n a n t
baculoviruses [26,27,45,46].
We have shown that the glycoproteins travel through
the ER, which is very sensitive to any homeostatic
alterations and disturbances. Such ER stress is induced
by protein misfolding, considerable protein overproduc-
tion and inhibition of N-linked glycosylation [47]. Gen-
erally, two baculovirus proteins cathepsin and chitinase
are abundantly expressed and the latter tends to accu-
mulate in the ER [48], thereby clogging up the ER and
competing with recombinant proteins. Even though
chitinase is deleted from the recombinant baculovirus
backbone, it appears that the CHIKV glycoproteins are
expressed in such massive amounts, that the unfolded
protein response (UPR), which is normally induced in
response to ER-stress [49], is not sufficient to mitigate
ER stress, as concluded from the fact that a fraction of
the 6KE1, 6KE1ΔTM, E3E2 and E3E2ΔTM appear in
their unprocessed forms. Incomplete glycosylation and
retention in the ER of intracellular viral glycoproteins
expressed at very high levels in baculovirus-infected
c e l l si sc o m m o n[ 5 0 ] ,b u tt h i sd i dn o tc o m p r o m i s e
membrane localization and subunit secretion.
While glycosylation of recombinant CHIKV-E1 and
-E2 was relatively efficient, expression analysis with the
baculoviruses Ac-E3E2 and -E3E2ΔTM indicated that
only a small fraction was cleaved by cellular furin. This,
however, did not prevent secretion of the uncleaved, gly-
cosylated E3E2 precursor as observed in the furin inhibi-
tion experiment and during metal-affinity
chromatographay purification of secreted E2 subunits.
We can therefore conclude that not furin activity, but
rather the accumulation and retention of non-glycosy-
lated E3E2 precursors in the ER, is limiting subunit
secretion. This phenomenon has been well described for
high level expression in insect cells of CSFV-E2, a simi-
lar glycoprotein from a different virus [50].
Although E3 plays a major role during CHIKV replica-
tion in the formation of E1 and E2 heterodimers [10],
and the presence of uncleaved E3E2 in progeny alpha-
virus particles induces defects in virus production [51],
it is not known if the presence of E3 has negative effects
on the stability, functionality or antigenicity of E2 subu-
nits. Considering that alphavirus virions with incorpo-
rated uncleaved E3E2 are able to bind efficiently to the
cell surface, which is modulated by E2 [52], we expect
that E3E2 is still sufficiently immunogenic. In fact, a
recent report has shown that E3 also harbours protec-
tive epitopes [53]. Future studies might further explicate
the effect of glycosylation on subunit antigenicity and
epitope presentation.
Confocal microscopy showed that E1 and E2 are pre-
sent at the surface of Sf21 cells. Since cells are able to
secrete uncleaved, but glycosylated E3E2ΔTM, it is likely
that cells expressing E3E2 display the protein in its gly-
cosylated configuration on the surface of the cell. The
reason that displayed or secreted proteins are all glyco-
sylated, might be explained simply by the fact that gly-
cosylation occurs prior to entering of the secretory
pathway. Cells infected with Ac-6KE1 were able to form
syncytia, indicating that E1 protein displayed at the sur-
face was able to induce membrane fusion. Subjecting
Ac-6KE1, Ac-E3E2 and Ac-GFP infected Sf9-ET cells to
a range of acidified Sf900 II medium (pH = 5.0, 5.5, 5.8
and 6.4) excluded the possibility that syncytia formation
was induced at pH 5.8 by the baculovirus fusion protein
GP64, which is also expressed at the surface of infected
cells [42]. The pH of Sf900 II medium was in the same
range as it would be during endocytosis (pH5.5-pH5.8).
Surprisingly, fusogenic activity was also shown at a pH
= 6.4, which is expected to be slightly out of the fuso-
genic range of E1. This phenomenon was most likely
caused by the addition of cholesterol to the culture
medium. Cholesterol is known to be an important factor
in alphavirus fusion [40], and a supplement activates
CHIKV-E1 to be fusogenic. Whether its fusogenicity
means that E1 is present in the form of homotrimers on
the surface of the cell needs experimental confirmation.
The virus neutralization test shows that the rabbit
polyclonal antiserum elicited against purified CHIKV-
E2ΔTM is able to neutralize CHIKV. This is the first
time that a secreted form of CHIKV-E2, expressed by
the recombinant baculovirus-insect cell expression sys-
tem elicits neutralizing antibodies in rabbits. No neutra-
lizing antibodies were detected in the serum of E1ΔTM
vaccinated rabbits, which is not entirely unexpected
since E1 is partially covered by E2 in mature virions
[54]. This is clear proof for antigenicity of the E2 subu-
nit vaccine candidate, which will now be further studied
in vaccination trials in an animal model. The fact that
expression of CHIKV-glycoproteins in insect cells results
in correct processing similar to the processing found
during wildtype infections, proposes it to be a very
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tion and development of alphavirus subunit vaccines. In
addition, proteins appear to retain their original func-
tion, paving the way for recombinant baculoviruses to
be used in functionality studies in insect cells.
Conclusions
In conclusion, this study has shown that expression of
full-length CHIKV 6KE1 and E3E2 glycoproteins using
baculovirus vectors in insect cells leads to glycosylation,
furin processing, plasma membrane translocation of E1
and E2, and CHIKV-E1 retains its functional activity as
a membrane fusion protein. In addition, the deletion of
the C-terminal transmembrane domain enables secre-
tion of glycoprotein E1 and E2 independent of furin
cleavage. The purified, glycosylated and secreted CHIKV
E2 subunit induced neutralizing antibodies in rabbits
and can now be tested for its ability to provide protec-
tion against CHIKV challenge in an animal model.
Methods
Cells and viruses
Spodoptera frugiperda (Sf21) insect cells (Invitrogen)
were maintained in tissue culture flasks (Greiner) as a
monolayer culture in Grace’si n s e c tm e d i u m( I n v i t r o -
gen), supplemented with 10% fetal bovine serum (FBS,
Hyclone). Sf9-easy titer (ET) cells [41] were maintained
as a monolayer culture in Sf900 II (Invitrogen) serum
free medium. The Bac-to-Bac baculovirus expression
system (Invitrogen) based upon Autographa californica
multicapsid nucleopolyhedrovirus (AcMNPV) was used
to generate recombinant baculoviruses. The bacmid
backbone AcΔcc contained a deletion of the promoters
and large parts of the ORFs of cathepsin and chitinase,
thereby leaving flanking essential genes intact [55].
Furthermore, the p10 promoter and ORF were deleted
from the AcΔcc backbone by replacing these elements
with a zeocin resistance marker by Lambda Red recom-
bination [56,57]. This zeocin resistance marker was
flanked by modified loxP sequences as described by [58]
for bacterial genome modifications. This allowed the
subsequent removal of the marker gene with Cre
recombinase.
Baculovirus titers were determined by end point dilu-
tion assay and expressed as tissue culture infectious
dose 50 (TCID50) per ml. Viral RNA of Chikungunya
virus isolate S27 (Tanzania, 1953) provided by Erasmus
Medical Center (EMC), Rotterdam, was used as a source
for cDNA synthesis.
CHIKV-S27 virus stocks were produced in BHK-21
cells in a BSL3 laboratory. Input virus was removed by
extensive washing, and supernatant containing infectious
virus was harvested four days post infection (pi) and fil-
tered. Virus titration assays were performed on BHK-21
cell monolayers in 96 wells plate and titer was calculated
using the Karber method. Virus stock titers were
expressed as TCID50 per ml. CHIKV stocks containing
10
7 TCID50 /ml were aliquoted and stored at -80°C.
Construction of recombinant baculoviruses encoding
CHIKV glycoproteins
Amplicons of CHIKV 6KE1 and E3E2 were generated
using SuperScript One-Step RT-PCR with Platinum Taq
(Invitrogen), cloned in pGEM-Teasy vectors (Promega)
and sequenced (Eurofins Operon, Germany). CHIKV
cDNA sequences encoding 6KE1, 6KE1ΔTM, E3E2 and
E3E2ΔT M( F i g u r e1 )w e r eP C Ra m p l i f i e df r o mt h e s e
plasmids using extended primers (6K-F; ggggacaagtttgta-
caaaaaagcaggcttaggatccaccatggccacataccaagaggctgc, E3-F;
ggggacaagtttgtacaaaaaagcaggcttaggatccaccatgagtcttgc-
catcccagttatg, E1-R; ggggaccactttgtacaagaaagctggg-
taaagcttctaatgatgatgatgatgatgcatgtgcctgctgaacgacacgc,
E1ΔTM-R; ggggaccactttgtacaagaaagctgggtaaagcttctaatgat-
gatgatgatgatgcatccatgacatcgccgtagcgg, E2-R; ggggac-
cactttgtacaagaaagctgggtaaagcttctaatgatgatgatgatgatgctg-
cagcgctttagctgttctgatgc and E2ΔTM-R;
ggggaccactttgtacaagaaagctgggtaaagcttctaatgatgatgatgat-
gatgctgcagcagctcataataatacagaa) that introduce AttB
recombination sites (underlined) to enable Gateway
®
cloning (Invitrogen). Resulting PCR products were
cloned into pDONR207 donor plasmid (Invitrogen) and
subsequently transferred to the pFastBac1 derivative
pDEST8 (Invitrogen). Recombinant baculoviruses encod-
ing the CHIKV protein constructs were generated using
the Bac-to-Bac baculovirus expression system (Invitro-
gen), resulting in Ac-6KE1, Ac-6KE1ΔTM, Ac-E3E2 and
Ac-E3E2ΔTM.
Protein analysis
For analysis of protein expression, 6 × 10
6 Sf21 cells
were seeded into 75 cm
2 culture flasks. Cells were
infected with recombinant virus at a multiplicity of
infection (MOI) of 10 TCID50 units per cell. Cells were
h a r v e s t e d7 2h p ia n dw a s h e dt w i c ei n1m lp h o s p h a t e
buffered saline (PBS). Finally, cells were resuspended in
500μl PBS and stored at -20°C. Whole cell lysates were
analyzed by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) and Coomassie brilliant
blue staining. A lysate of CHIKV-infected Ap61 mos-
quito cells was used as positive control. Proteins were
transferred to an immobilon transfer membrane (Milli-
pore) for Western blot (WB) analyses. Membranes were
blocked in PBS + 0.1% Tween-60 (PBST) containing 3%
skim milk for 1 h at 37°C. Next, the membranes were
washed with PBST and incubated with rabbit polyclonal
antiserum (supplied by Nobilon International BV) at a
dilution of 1:15,000 for 1 h at 37°C. After incubation,
membranes were washed and treated with 1:3,000
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rabbit IgG antibodies (Sigma) for 45 min at 37°C. Pro-
teins were detected by NBT/BCIP staining (Roche).
Tunicamycin assay
A tunicamycin assay was performed to analyze the gly-
cosylation status of recombinant CHIKV E1 and E2.
Sf21 cells were infected with recombinant baculoviruses
at an MOI of 10 TCID50 units per cell. Cells were incu-
bated at 27°C in the presence of 10 μg/ml tunicamycin
(Sigma) and harvested 72 hpi. Protein glycosylation was
visualized using Western blotting and Periodic acid
Schiff staining. Proteins were blotted on an immobilon
transfer membrane (Millipore) and soaked in PAS solu-
tion (1% perjodium acid in 3% acetic acid) for 15 min at
room temperature (RT). The membrane was washed
several times in water and was incubated in the dark for
15 minutes at RT with Schiff’s reagent. Finally, the
membrane was washed for 5 min in 50% Na2CO3.
Furin inhibition assay
Sf21 cells were infected with Ac-E3E2 and E3E2ΔTM at
an MOI of 10 in Grace’s insect medium (Invitrogen)
without FBS. Cells were washed twice with medium and
incubated with medium containing 50 μM of Furin Inhi-
bitor I (Calbiochem). Cells were harvested at 72 hpi and
the medium fraction was separated from the cell frac-
tion by centrifugation. Protein processing was analyzed
by Western blotting.
Immunostaining of baculovirus infected Sf21 cells
Sf21 cells were infected with Ac-E3E2 and Ac-6KE1 at a
MOI of 10 to determine surface expression of CHIKV-
E1 and -E2. Cells were harvested 48 hpi and washed
with PBS. Next, the cells were incubated for 1 h at RT
with PBS+5%FBS containing 1:5,000 diluted rabbit a-
CHIKV-E1 and rabbit a-CHIKV-E2 polyclonal antibo-
dies. Cells were washed 3 times and incubated for 1 h at
RT with PBS+5%FBS containing 1:1,000 diluted goat-
anti-rabbit-Alexa Fluor 488 (Invitrogen). Cells were ana-
lyzed using laser scanning confocal microscopy on a
Z e i s sL S M5 1 0M e t a ,A x i o v e r t1 0 0m( Z e i s s )w i t h
Argon laser (488 nm) and images were analyzed with
Zeiss LSM image browser.
Syncytium formation assay
The syncytium formation assay was performed by infect-
ing Sf9-easy titer (ET) cells [41] with Ac-E3E2,Ac-6KE1
at an MOI of 10 in Sf900 II medium (pH = 6.4 ), sup-
plemented with cholesterol (0.2 mg/ml, Sigma). A
recombinant AcMNPV expressing GFP (Ac-GFP) was
used as a negative control. Syncytium formation was
induced 72 hpi, by subjecting infected cells for 2 min-
utes to acidified medium with pH = 5.8, pH = 5.5 and
pH = 5.0. Syncytium formation was scored 4 h post
induction using fluorescence microscopy.
Purification of secreted CHIKV-E1 and -E2 subunits from
insect cells
Sf21 cells were infected with Ac-6KE1ΔTM and Ac-
E3E2ΔTM at an MOI of 10 in Grace’si n s e c tm e d i u m
without FBS and were incubated for 72 h at 27°C. The
recombinant proteins were purified from the medium
fraction using Talon
® spin columns (Clontech) accord-
ing to the manufacturer’s protocol. Bound protein frac-
tions were eluted with 150 mM imidazol and total
protein content was determined via a Bradford protein
assay (Biorad) according to the manufacturer’s
procedure.
Virus neutralization test
Virus neutralizing antibody titers in sera of rabbits vac-
cinated with purified CHIKV-E1ΔTM and E2ΔTM, were
determined as follows. Serial two-fold dilutions of heat-
inactivated rabbit sera were prepared in triplicate in 96-
wells plate and 100 TCID50 of CHIKV suspension was
added to each well. After one hour of incubation at 37°
C, 1 × 10
4 BHK-21 cells were added to each well and
plates were incubated for another four days. Neutraliz-
ing titers were determined microscopically and
expressed as the reciprocal of the highest serum dilution
still giving 100% suppression of cytopathic effect.
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